Adaptilens, founded by Liane Clamen, MD, focuses on revolutionizing vision care through the development of accommodating intraocular lenses (IOLs) that closely mimic the human eye's natural lens. The company's mission is to enhance the vision and quality of life for cataract patients by providing lenses that adapt to various distances, reducing the need for glasses or contact lenses. Their innovative IOLs aim to restore the eye's ability to focus on objects near, far, and in between.

Notable figures affiliated with Adaptilens include Brett Thomes, PhD, Chief Information and Technology Officer, and Daniel Stanley, MS, Chief Scientist. The company has garnered attention for its groundbreaking approach to vision correction, positioning itself as a leader in ophthalmic innovation. By addressing a significant need in the cataract treatment market, Adaptilens has made a substantial impact on improving patient outcomes and advancing the field of eye care.